Kerri A Kendrick

Doctor, Urology

Phone+1-210-567-5676
Emailkendrick@uthscsa.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Kerri A Kendrick is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

4 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

219 Citations
3 h-Index
3 Article

Predictors of Recurrence, and Progression-Free and Overall Survival following Open versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year Followup
Venkatramani, V., Reis, I. M., Castle, E. P., Gonzalgo, M. L., Woods, M. E., Svatek, R. S., Weizer, A. Z., Konety, B. R., Tollefson, M., Krupski, T. L., Smith, N. D., Shabsigh, A., Barocas, D. A., Quek, M. L., Dash, A., Kibel, A. S., Pruthi, R. S., Montgomery, J. S., Weight, C. J., Sharp, D. S. & 13 others, Chang, S. S., Cookson, M. S., Gupta, G. N., Gorbonos, A., Uchio, E. M., Skinner, E., Soodana-Prakash, N., Becerra, M. F., Swain, S., Kendrick, K., Smith, J. A., Thompson, I. M. & Parekh, D. J., Mar 1 2020, In: The Journal of urology. 203, 3, p. 522-529 8 p.
Research output: Contribution to journal › Article › peer-review
14 Scopus citations
Intratumoral CD56^bright natural killer cells are associated with improved survival in bladder cancer
Mukherjee, N., Ji, N., Hurez, V., Curiel, T. J., Montgomery, M. O., Braun, A. J., Nicolas, M., Aguilera, M., Kaushik, D., Liu, Q., Ruan, J., Kendrick, K. A. & Svatek, R. S., Nov 1 2018, In: Oncotarget. 9, 92, p. 36492-36502 11 p.
Research output: Contribution to journal › Article › peer-review
12 Scopus citations
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
Parekh, D. J., Reis, I. M., Castle, E. P., Gonzalgo, M. L., Woods, M. E., Svatek, R. S., Weizer, A. Z., Konety, B. R., Tollefson, M., Krupski, T. L., Smith, N. D., Shabsigh, A., Barocas, D. A., Quek, M. L., Dash, A., Kibel, A. S., Shemanski, L., Pruthi, R. S., Montgomery, J. S., Weight, C. J. & 12 others, Sharp, D. S., Chang, S. S., Cookson, M. S., Gupta, G. N., Gorbonos, A., Uchio, E. M., Skinner, E., Venkatramani, V., Soodana-Prakash, N., Kendrick, K., Smith, J. A. & Thompson, I. M., Jun 23 2018, In: The Lancet. 391, 10139, p. 2525-2536 12 p.
Research output: Contribution to journal › Article › peer-review
193 Scopus citations

A Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer
Robert Svatek & Kerri A Kendrick
10/2/18
1 item of Media coverage
Press/Media: Press / Media
Surveillance for Low and Low-Intermediate Risk Non-muscle Invasive Bladder Cancer: A Pilot Study
Robert Svatek & Kerri A Kendrick
10/2/18
1 item of Media coverage
Press/Media: Press / Media

Predictors of Recurrence, and Progression-Free and Overall Survival following Open versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year Followup

Intratumoral CD56bright natural killer cells are associated with improved survival in bladder cancer

Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial

A Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer

Surveillance for Low and Low-Intermediate Risk Non-muscle Invasive Bladder Cancer: A Pilot Study

Intratumoral CD56^bright natural killer cells are associated with improved survival in bladder cancer